Roman Butler Fullerton & Co’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,220
| Closed | -$203K | – | 187 |
|
|
2023
Q2 | $203K | Sell |
2,220
-300
| -12% | -$27.5K | 0.09% | 183 |
|
|
2023
Q1 | $221K | Buy |
+2,520
| New | +$221K | 0.11% | 177 |
|
|
2022
Q4 | – | Sell |
-2,520
| Closed | -$207K | – | 192 |
|
|
2022
Q3 | $207K | Hold |
2,520
| – | – | 0.13% | 167 |
|
|
2022
Q2 | $251K | Hold |
2,520
| – | – | 0.14% | 161 |
|
|
2022
Q1 | $297K | Hold |
2,520
| – | – | 0.14% | 160 |
|
|
2021
Q4 | $326K | Hold |
2,520
| – | – | 0.14% | 146 |
|
|
2021
Q3 | $280K | Hold |
2,520
| – | – | 0.13% | 160 |
|
|
2021
Q2 | $261K | Hold |
2,520
| – | – | 0.13% | 162 |
|
|
2021
Q1 | $222K | Hold |
2,520
| – | – | 0.11% | 183 |
|
|
2020
Q4 | $230K | Hold |
2,520
| – | – | 0.14% | 159 |
|
|
2020
Q3 | $201K | Buy |
+2,520
| New | +$201K | 0.13% | 153 |
|
|
2020
Q1 | – | Sell |
-3,180
| Closed | -$247K | – | 145 |
|
|
2019
Q4 | $247K | Buy |
+3,180
| New | +$247K | 0.16% | 148 |
|